96P: Enhanced anti-tumor activity of zelenectide pevedotin in patients (pts) with non-small cell lung cancer (NSCLC) with NECTIN4 gene amplification (amp)

L. Verlingue, N. Klümper, M. Eckstein, J. Braegelmann, M. McKean, A. Italiano, L. Carter, G.S. Falchook, V. Boni, A. Dowlati, B. Doger De Spéville, E. Fontana, J. Rodon, L. Demars, G. Brown, C. Xu, C. Campbell, T. Gelb, S. Santos, C. Baldini

Research output: Contribution to conference › Abstract › peer-review

Fingerprint

Dive into the research topics of '96P: Enhanced anti-tumor activity of zelenectide pevedotin in patients (pts) with non-small cell lung cancer (NSCLC) with NECTIN4 gene amplification (amp)'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science